Showing results (11-20 of 122) with videos related to

Sort By:
Pageof 13
Breast Cancer Research and Treatment|July 25, 2012
Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cellsWarren Fiskus, Stacey L Hembruff, Rekha Rao, et al.
Molecular Cancer Therapeutics|February 28, 2012
Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cellsRekha Rao, Ramesh Balusu, Warren Fiskus, et al.
Molecular Cancer Therapeutics|July 24, 2014
BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITDWarren Fiskus, Sunil Sharma, Jun Qi, et al.
Molecular Cancer Therapeutics|July 29, 2010
Heat shock protein 90 inhibition depletes TrkA levels and signaling in human acute leukemia cellsRekha Rao, Srilatha Nalluri, Warren Fiskus, et al.
Annual Review of Medicine|January 16, 2016
B-Raf Inhibition in the Clinic: Present and FutureWarren Fiskus, Nicholas Mitsiades
Pharmacotherapy|June 26, 2013
Preclinical and phase I results of decitabine in combination with midostaurin (PKC412) for newly diagnosed elderly or relapsed/refractory adult patients with acute myeloid leukemiaCasey B Williams, Suman Kambhampati, Warren Fiskus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2010
Role of CAAT/enhancer binding protein homologous protein in panobinostat-mediated potentiation of bortezomib-induced lethal endoplasmic reticulum stress in mantle cell lymphoma cellsRekha Rao, Srilatha Nalluri, Warren Fiskus, et al.
Molecular Cancer Therapeutics|April 8, 2010
Treatment with panobinostat induces glucose-regulated protein 78 acetylation and endoplasmic reticulum stress in breast cancer cellsRekha Rao, Srilatha Nalluri, Ravindra Kolhe, et al.
Cancer Biology & Therapy|March 13, 2009
Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances decitabine mediated de-repression of JunB and loss of survival of human acute leukemia cellsWarren Fiskus, Kate Buckley, Rekha Rao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Heat shock protein 90 inhibitor is synergistic with JAK2 inhibitor and overcomes resistance to JAK2-TKI in human myeloproliferative neoplasm cellsWarren Fiskus, Srdan Verstovsek, Taghi Manshouri, et al.
Pageof 13